Danaher Will Top Dental Market With $2.2 Billion Nobel Biocare Buy
This article was originally published in The Gray Sheet
Executive Summary
The deal will give Danaher the largest share of the dental implants market, and the overall dental industry, including sales of consumables and equipment approaching $3 billion.
You may also be interested in...
Device/Diagnostics Quarterly Deal Statistics, Q3 2014
Device financing decreased to $734 million in Q3, less than half the Q2 total, and the $4.9 billion in M&As was a sharp decline versus Q2. Diagnostics fundraising, at $399 million, showed a 31% drop from Q2, and Merck KGAA’s $16.7 billion buy of Sigma-Aldrich made up 96% of the Q3 M&A activity.
M&A Ahead: Ten Potential Medtech Takeover Targets
Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.